New Strategy Study of Functional Cure of Chronic Hepatitis B

Summary

As HBsAg clearance is uncommon in chronic hepatitis B (CHB) patients on nucleoside analogues (NAs) therapy. The purpose of this study is to optimize HBsAg clearance in CHB Patients with sequential treatment of pegylated interferon alpha-2b and NAs.

Timeline

Start

2016-03

Primary completion

2017-09

Completion

—

Drugs

Indications